Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).

LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette TF, Lang ALS, Gillis HD, Martin I, Demczuk W, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, McCarthy AE, McGeer A, Semret M, Trottier S, Valiquette L, Webster D, McNeil SA.

Vaccine. 2019 Aug 23;37(36):5466-5473. doi: 10.1016/j.vaccine.2019.05.003. Epub 2019 Jul 23.

2.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.

LeBlanc JJ, ElSherif M, Mulpuru S, Warhuus M, Ambrose A, Andrew M, Boivin G, Bowie W, Chit A, Dos Santos G, Green K, Halperin SA, Hatchette TF, Ibarguchi B, Johnstone J, Katz K, Langley JM, Lagacé-Wiens P, Loeb M, Lund A, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA.

J Med Microbiol. 2019 Jul 2. doi: 10.1099/jmm.0.001032. [Epub ahead of print]

PMID:
31264957
3.

Antimicrobial Resistance in the Tropics.

Semret M, Haraoui LP.

Infect Dis Clin North Am. 2019 Mar;33(1):231-245. doi: 10.1016/j.idc.2018.10.009. Review.

PMID:
30712764
4.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.

Mulpuru S, Li L, Ye L, Hatchette T, Andrew MK, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Chest. 2019 Jan;155(1):69-78. doi: 10.1016/j.chest.2018.10.044.

PMID:
30616737
5.

Opportunities and barriers to implementing antibiotic stewardship in low and middle-income countries: Lessons from a mixed-methods study in a tertiary care hospital in Ethiopia.

Gebretekle GB, Haile Mariam D, Abebe W, Amogne W, Tenna A, Fenta TG, Libman M, Yansouni CP, Semret M.

PLoS One. 2018 Dec 20;13(12):e0208447. doi: 10.1371/journal.pone.0208447. eCollection 2018.

6.

The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.

Nichols MK, Andrew MK, Ye L, Hatchette TF, Ambrose A, Boivin G, Bowie W, Dos Santos G, Elsherif M, Green K, Haguinet F, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Sharma R, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Clin Infect Dis. 2019 Aug 30;69(6):970-979. doi: 10.1093/cid/ciy1009.

PMID:
30508064
7.

Point-of-care and point-of-'can': leveraging reference-laboratory capacity for integrated diagnosis of fever syndromes in the tropics.

Semret M, Ndao M, Jacobs J, Yansouni CP.

Clin Microbiol Infect. 2018 Aug;24(8):836-844. doi: 10.1016/j.cmi.2018.03.044. Epub 2018 Apr 10. Review.

8.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Lagacé-Wiens P, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Schuind A, Semret M, Shinde V, Smith S, Smyth D, Stiver G, Taylor G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN).

Vaccine. 2018 Apr 12;36(16):2166-2175. doi: 10.1016/j.vaccine.2018.02.093. Epub 2018 Mar 13.

PMID:
29548608
9.

Clinical bacteriology in low-resource settings: today's solutions.

Ombelet S, Ronat JB, Walsh T, Yansouni CP, Cox J, Vlieghe E, Martiny D, Semret M, Vandenberg O, Jacobs J; Bacteriology in Low Resource Settings working group.

Lancet Infect Dis. 2018 Aug;18(8):e248-e258. doi: 10.1016/S1473-3099(18)30093-8. Epub 2018 Mar 5. Review.

PMID:
29519767
10.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.

Andrew MK, Shinde V, Hatchette T, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Nichols MK, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN).

BMC Infect Dis. 2017 Dec 29;17(1):805. doi: 10.1186/s12879-017-2905-8.

11.

A recurrent hydatid cyst of the thigh diagnosed 13 years after initial presentation.

Barkati S, Butler-Laporte G, Ndao M, Kabiawu Ajise O, Semret M, Yansouni CP, Libman M.

IDCases. 2017 Nov 23;11:12-15. doi: 10.1016/j.idcr.2017.11.008. eCollection 2018.

12.

Multiplex Respiratory Virus Testing for Antimicrobial Stewardship: A Prospective Assessment of Antimicrobial Use and Clinical Outcomes Among Hospitalized Adults.

Semret M, Schiller I, Jardin BA, Frenette C, Loo VG, Papenburg J, McNeil SA, Dendukuri N.

J Infect Dis. 2017 Nov 15;216(8):936-944. doi: 10.1093/infdis/jix288.

13.

Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network.

Ng C, Ye L, Noorduyn SG, Hux M, Thommes E, Goeree R, Ambrose A, Andrew MK, Hatchette T, Boivin G, Bowie W, ElSherif M, Green K, Johnstone J, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Poirier A, Powis J, Richardson D, Sharma R, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN) Investigators; Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators.

Influenza Other Respir Viruses. 2018 Mar;12(2):232-240. doi: 10.1111/irv.12521. Epub 2018 Jan 24.

14.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.

Andrew MK, Shinde V, Ye L, Hatchette T, Haguinet F, Dos Santos G, McElhaney JE, Ambrose A, Boivin G, Bowie W, Chit A, ElSherif M, Green K, Halperin S, Ibarguchi B, Johnstone J, Katz K, Langley J, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McGeer A, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) and the Toronto Invasive Bacterial Diseases Network (TIBDN).

J Infect Dis. 2017 Aug 15;216(4):405-414. doi: 10.1093/infdis/jix282.

15.

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study.

LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Li L, Ambrose A, Hatchette TF, Lang AL, Gillis H, Martin I, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, McCarthy A, McGeer A, Moraca S, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Vaccine. 2017 Jun 22;35(29):3647-3654. doi: 10.1016/j.vaccine.2017.05.049. Epub 2017 May 26.

16.

Evaluating the impact of the multiplex respiratory virus panel polymerase chain reaction test on the clinical management of suspected respiratory viral infections in adult patients in a hospital setting.

Yee C, Suarthana E, Dendukuri N, Nicolau I, Semret M, Frenette C.

Am J Infect Control. 2016 Nov 1;44(11):1396-1398. doi: 10.1016/j.ajic.2016.04.221. Epub 2016 Jun 13.

PMID:
27311514
17.

Cleaning the grey zones of hospitals: A prospective, crossover, interventional study.

Semret M, Dyachenko A, Ramman-Haddad L, Belzile E, McCusker J.

Am J Infect Control. 2016 Dec 1;44(12):1582-1588. doi: 10.1016/j.ajic.2016.04.234. Epub 2016 Jul 7.

PMID:
27397907
18.

A Case of Polyarticular Pasteurella multocida Septic Arthritis.

Nitoslawski S, McConnell TM, Semret M, Stein MA.

Can J Infect Dis Med Microbiol. 2016;2016:5025697. doi: 10.1155/2016/5025697. Epub 2016 Apr 11.

19.

Bacteremia caused by a mecA-positive oxacillin-susceptible Staphylococcus aureus strain with inducible resistance.

Kong LY, Jean A, Wong H, Semret M, Frenette C, Simor AE, Fenn S, Loo VG.

Diagn Microbiol Infect Dis. 2015 Dec;83(4):377-8. doi: 10.1016/j.diagmicrobio.2015.09.001. Epub 2015 Sep 4. No abstract available.

PMID:
26422086
20.

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

McNeil S, Shinde V, Andrew M, Hatchette T, Leblanc J, Ambrose A, Boivin G, Bowie W, Diaz-Mitoma F, Elsherif M, Green K, Haguinet F, Halperin S, Ibarguchi B, Katz K, Langley J, Lagace-Wiens P, Light B, Loeb M, McElhaney J, Mackinnon-Cameron D, McCarthy A, Poirier M, Powis J, Richardson D, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McGeer A; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network; Toronto Invasive Bacterial Diseases Network (TIBDN).

Euro Surveill. 2014 Mar 6;19(9). pii: 20729.

21.

Severity and outcome associated with human coronavirus OC43 infections among children.

Jean A, Quach C, Yung A, Semret M.

Pediatr Infect Dis J. 2013 Apr;32(4):325-9. doi: 10.1097/INF.0b013e3182812787.

PMID:
23337903
22.

Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury.

Schinstock CA, Semret MH, Wagner SJ, Borland TM, Bryant SC, Kashani KB, Larson TS, Lieske JC.

Nephrol Dial Transplant. 2013 May;28(5):1175-85. doi: 10.1093/ndt/gfs127. Epub 2012 Apr 23.

PMID:
22529161
23.

Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors.

Rule AD, Semret MH, Amer H, Cornell LD, Taler SJ, Lieske JC, Melton LJ 3rd, Stegall MD, Textor SC, Kremers WK, Lerman LO.

Mayo Clin Proc. 2011 Apr;86(4):282-90. doi: 10.4065/mcp.2010.0821. Erratum in: Mayo Clin Proc. 2011 May;86(5):469.

24.

Renal involvement in Neimann-Pick Disease.

Grafft CA, Fervenza FC, Semret MH, Orloff S, Sethi S.

NDT Plus. 2009 Dec;2(6):448-51. doi: 10.1093/ndtplus/sfp101. Epub 2009 Aug 10.

25.

A near-fatal infection with oseltamivir-resistant seasonal influenza A in a previously healthy child: Case report.

Papenburg J, Karatzios C, Li Y, Bastien N, Semret M, Moore D.

Can J Infect Dis Med Microbiol. 2009 Winter;20(4):e173-6.

26.

A magician's tale.

Semret M, Law A, Turner S, de Varennes B, Ward BJ, Huynh T.

Can J Infect Dis Med Microbiol. 2006 Mar;17(2):133-4. No abstract available.

27.

Visualization of Mycobacterium avium in Crohn's tissue by oil-immersion microscopy.

Jeyanathan M, Boutros-Tadros O, Radhi J, Semret M, Bitton A, Behr MA.

Microbes Infect. 2007 Nov-Dec;9(14-15):1567-73. Epub 2007 Sep 11.

PMID:
18062905
28.

Genetic analysis of Mycobacterium avium complex strains used for producing purified protein derivatives.

Semret M, Bakker D, Smart N, Olsen I, Haslov K, Behr MA.

Clin Vaccine Immunol. 2006 Sep;13(9):991-6.

29.

Insertion sequence IS900 revisited.

Semret M, Turenne CY, Behr MA.

J Clin Microbiol. 2006 Mar;44(3):1081-3.

30.

Differentiating host-associated variants of Mycobacterium avium by PCR for detection of large sequence polymorphisms.

Semret M, Turenne CY, de Haas P, Collins DM, Behr MA.

J Clin Microbiol. 2006 Mar;44(3):881-7.

31.

Isolation of the genome sequence strain Mycobacterium avium 104 from multiple patients over a 17-year period.

Horan KL, Freeman R, Weigel K, Semret M, Pfaller S, Covert TC, van Soolingen D, Leão SC, Behr MA, Cangelosi GA.

J Clin Microbiol. 2006 Mar;44(3):783-9.

32.

Sequencing of hsp65 distinguishes among subsets of the Mycobacterium avium complex.

Turenne CY, Semret M, Cousins DV, Collins DM, Behr MA.

J Clin Microbiol. 2006 Feb;44(2):433-40.

33.

The two-component regulatory system mtrAB is required for morphotypic multidrug resistance in Mycobacterium avium.

Cangelosi GA, Do JS, Freeman R, Bennett JG, Semret M, Behr MA.

Antimicrob Agents Chemother. 2006 Feb;50(2):461-8.

34.
35.

Genomic polymorphisms for Mycobacterium avium subsp. paratuberculosis diagnostics.

Semret M, Alexander DC, Turenne CY, de Haas P, Overduin P, van Soolingen D, Cousins D, Behr MA.

J Clin Microbiol. 2005 Aug;43(8):3704-12.

36.

A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy.

Agarwal R, Saha C, Battiwala M, Vasavada N, Curley T, Chase SD, Sachs N, Semret MH.

Kidney Int. 2005 Jul;68(1):285-92.

37.

Extensive genomic polymorphism within Mycobacterium avium.

Semret M, Zhai G, Mostowy S, Cleto C, Alexander D, Cangelosi G, Cousins D, Collins DM, van Soolingen D, Behr MA.

J Bacteriol. 2004 Sep;186(18):6332-4.

38.

Crohn's disease, mycobacteria, and NOD2.

Behr MA, Semret M, Poon A, Schurr E.

Lancet Infect Dis. 2004 Mar;4(3):136-7. No abstract available.

PMID:
14998497
39.

Helicobacter DNA in bile: correlation with hepato-biliary diseases.

Fallone CA, Tran S, Semret M, Discepola F, Behr M, Barkun AN.

Aliment Pharmacol Ther. 2003 Feb;17(3):453-8.

40.

Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.

Semret M, Miller MA.

Infect Control Hosp Epidemiol. 2001 Sep;22(9):578-80.

PMID:
11732789
41.

Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.

Semret M, Koromihis G, MacLean JD, Libman M, Ward BJ.

Am J Trop Med Hyg. 1999 Nov;61(5):689-93.

PMID:
10586895
42.

Ritanserin decreases portal pressure in conscious and unrestrained cirrhotic rats.

Mastai R, Giroux L, Semret M, Huet PM.

Gastroenterology. 1990 Jan;98(1):141-5.

PMID:
2104540

Supplemental Content

Loading ...
Support Center